Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — April 2024

Biotek-snakken — April 2024

Planlagt Fastgjort Låst Flyttet Biotek-snakken
112 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • F Offline
    F Offline
    Fandel
    wrote on sidst redigeret af
    #37

    Godmorgen...

    1 Reply Last reply
    0
    • L Offline
      L Offline
      LP90
      wrote on sidst redigeret af
      #38

      Godmorgen 🙂

      1 Reply Last reply
      0
      • F Offline
        F Offline
        Fandel
        wrote on sidst redigeret af
        #39

        Godmorgen...

        1 Reply Last reply
        0
        • L Offline
          L Offline
          LP90
          wrote on sidst redigeret af
          #40

          God morgen 🙂

          1 Reply Last reply
          0
          • exitnuE Offline
            exitnuE Offline
            exitnu
            wrote on sidst redigeret af
            #41

            Calliditas Therapeutics: Pareto 16/4-24; Buy - Target SEK 161 / Share price SEK 101.

            1 Reply Last reply
            0
            • exitnuE Offline
              exitnuE Offline
              exitnu
              wrote on sidst redigeret af
              #42

              "Comments
              Calliditas delivered strong Q4 results and with Tarpeyo’s full FDA
              approval granted in December 2023, we have decided to update
              our estimates according to the current trajectory. With the sales
              unleashing full approval(s) and weak competition, ...

              1 Reply Last reply
              0
              • exitnuE Offline
                exitnuE Offline
                exitnu
                wrote on sidst redigeret af
                #43

                ... we remain
                optimistic and expect the first (organically) profitable quarter to be
                Q3 2024 – if the company continues to step up its commercial
                efforts. With the updated forecasts, we have reached a fair value
                of SEK 177 but have decided to maintain our target price of SEK
                161 due to low growth expected for Q1 2024."

                1 Reply Last reply
                0
                • exitnuE Offline
                  exitnuE Offline
                  exitnu
                  wrote on sidst redigeret af
                  #44

                  "Pareto upprepar köp för Calliditas inför rapporten - fortsatt optimistiska"

                  (Finwire)

                  1 Reply Last reply
                  0
                  • F Offline
                    F Offline
                    Fandel
                    wrote on sidst redigeret af
                    #45

                    Godmorgen...

                    1 Reply Last reply
                    0
                    • Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktør
                      wrote on sidst redigeret af
                      #46

                      Alvotech And Teva : FDA Approves Selarsdi Injection For Psoriasis And Psoriatic Arthritis https://www.proinvestor.com/investornyt/1145923/alvotech-and-teva-fda-approves-selarsdi-injection-for-psoriasis-and-psoriatic-arthritis

                      1 Reply Last reply
                      0
                      • L Offline
                        L Offline
                        LP90
                        wrote on sidst redigeret af
                        #47

                        Godmorgen 🙂

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          ProinvestorNEWS
                          wrote on sidst redigeret af
                          #48

                          ULTIMOVACS: Biotekselskapet melder at de vil redusere antall ansatte med 40% slik at de skal ha likviditet til å nå ytterligere to datapunkter - pengene skal etter plan holde til Q4 2025.

                          1 Reply Last reply
                          0
                          • F Offline
                            F Offline
                            Fandel
                            wrote on sidst redigeret af
                            #49

                            Godmorgen...

                            1 Reply Last reply
                            0
                            • L Offline
                              L Offline
                              LP90
                              wrote on sidst redigeret af
                              #50

                              Godmorgen 🙂

                              1 Reply Last reply
                              0
                              • exitnuE Offline
                                exitnuE Offline
                                exitnu
                                wrote on sidst redigeret af
                                #51

                                Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024

                                Link Preview Image
                                Calliditas Therapeutics AB

                                Calliditas is a commercial stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs.

                                favicon

                                Calliditas Therapeutics AB (www.calliditas.se)

                                1 Reply Last reply
                                0
                                • F Offline
                                  F Offline
                                  Fandel
                                  wrote on sidst redigeret af
                                  #52

                                  Godmorgen...

                                  1 Reply Last reply
                                  0
                                  • L Offline
                                    L Offline
                                    LP90
                                    wrote on sidst redigeret af
                                    #53

                                    Godmorgen 🙂

                                    1 Reply Last reply
                                    0
                                    • F Offline
                                      F Offline
                                      Fandel
                                      wrote on sidst redigeret af
                                      #54

                                      Godmorgen...

                                      1 Reply Last reply
                                      0
                                      • F Offline
                                        F Offline
                                        Fandel
                                        wrote on sidst redigeret af
                                        #55

                                        Godmorgen...

                                        1 Reply Last reply
                                        0
                                        • Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktør
                                          wrote on sidst redigeret af
                                          #56

                                          BioArctic And Eisai Collaborate On Evaluating BAN2802 For Alzheimer's Disease https://www.proinvestor.com/investornyt/1148131/bioarctic-and-eisai-collaborate-on-evaluating-ban2802-for-alzheimers-disease

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper